Opportunity overview
NHS Greater Glasgow and Clyde (NHSGGC) are tendering for Radiopharmaceuticals and associated products. NHS Greater Glasgow and Clyde (NHSGGC) is the largest of the fourteen territorial NHS Boards in Scotland. The radiopharmacy service provides individually prepared doses to patients within NHSGGC, NHS Forth Valley, NHS Ayrshire & Arran and NHS Lanarkshire. The doses produced are used in 13 Nuclear Medicine departments across these boards. NHS Greater Glasgow and Clyde Radionuclide Dispensary service is located in North Glasgow Sector within the Acute Division of NHSGGC. The service is responsible for the production of outpatient and inpatient radiopharmaceutical doses to patients of the four west and central Scotland health boards as above. We also provide some doses to University or commercial customers. We aim to deliver a timely, high quality, patient centred service to all our service users in line with NHSGGC’s quality aims and the Quality Strategy. We use the evidence base at all times to ensure we are delivering the most up to date care for our patients. The service produces around 30,000 doses each year and also acts as a central delivery point for radioactive commercial packages for NHSGGC nuclear medicine departments.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Adelphi Tubes
- Shared contract value
- £8.5m
- Awarded
- Not supplied
- Contract signed
- 1 Nov 2024
- Suppliers
- One of 4 awarded suppliers
- Award ID
- 002609-2025-GGC0814-1
- Status
- active
- Location
- Haywards Heath, UKJ27, RH16 1XQ, United Kingdom
Curium Pharma UK Ltd
- Shared contract value
- £8.5m
- Awarded
- Not supplied
- Contract signed
- 1 Nov 2024
- Suppliers
- One of 4 awarded suppliers
- Award ID
- 002609-2025-GGC0814-1
- Status
- active
- Location
- PortsmoutH, UK, PO6 3EZ, United Kingdom
GE Healthcare LTD
- Shared contract value
- £8.5m
- Awarded
- Not supplied
- Contract signed
- 1 Nov 2024
- Suppliers
- One of 4 awarded suppliers
- Award ID
- 002609-2025-GGC0814-1
- Status
- active
- Location
- Chalfont Saint Giles, UK, HP8 4SP, United Kingdom
Xiel Limited
- Shared contract value
- £8.5m
- Awarded
- Not supplied
- Contract signed
- 1 Nov 2024
- Suppliers
- One of 4 awarded suppliers
- Award ID
- 002609-2025-GGC0814-1
- Status
- active
- Location
- Shepton Mallet, UKK23, BA4 4JT, United Kingdom
Classification
- CPV09343000 — Radioactive materials
Lots
- NHS Greater Glasgow and Clyde (NHSGGC) are tendering for Radiopharmaceuticals and associated products. NHS Greater Glasgow and Clyde (NHSGGC) is the largest of the fourteen territorial NHS Boards in Scotland. The radiopharmacy service provides individually prepared doses to patients within NHSGGC, NHS Forth Valley, NHS Ayrshire & Arran and NHS Lanarkshire. The doses produced are used in 13 Nuclear Medicine departments across these boards. NHS Greater Glasgow and Clyde Radionuclide Dispensary service is located in North Glasgow Sector within the Acute Division of NHSGGC. The service is responsible for the production of outpatient and inpatient radiopharmaceutical doses to patients of the four west and central Scotland health boards as above. We also provide some doses to University or commercial customers. We aim to deliver a timely, high quality, patient centred service to all our service users in line with NHSGGC’s quality aims and the Quality Strategy. We use the evidence base at all times to ensure we are delivering the most up to date care for our patients. The service produces around 30,000 doses each year and also acts as a central delivery point for radioactive commercial packages for NHSGGC nuclear medicine departments.Value not stated